Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction

Back

HFA Premium Access

Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction

Session: Basic science

Topic: Drugs, Drug Targets

Speaker: Miss D. Martinez-Falguera (Badalona, ES)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Miss Daina Martinez-Falguera

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)

1 presentation

0 follower

4 more presentations in this session

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

Speaker: Mr I. Dias (Groningen, NL)

Unravelling the diversity of cholinesterases in the murine heart as an essential prerequisite for the use of cholinesterase inhibitors in the treatment of heart failure

Speaker: Associate Professor A. Hrabovska (Bratislava, SK)

Cellular phenotyping of structural and functional changes in atrial myopathy

Speaker: Doctor J. Huettemeister (Berlin, DE)

Non-dilated left ventricular cardiomyopathy with arrhythmias is caused by the nonsense founder variant DSP:c.3793G>T in Slovenian patients

Speaker: Ms N. Vodnjov (Ljubljana, SI)

Access the full session

Basic science

Speakers: Miss D. Martinez-Falguera, Mr I. Dias, Associate Professor A. Hrabovska, Doctor J. Huettemeister, Ms N. Vodnjov

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources